scispace - formally typeset
K

Karolina Jagiello

Researcher at University of Gdańsk

Publications -  44
Citations -  505

Karolina Jagiello is an academic researcher from University of Gdańsk. The author has contributed to research in topics: Medicine & Quantitative structure–activity relationship. The author has an hindex of 11, co-authored 32 publications receiving 314 citations. Previous affiliations of Karolina Jagiello include Gdańsk University of Technology.

Papers
More filters
Journal Article

[NADPH-cytochrome P450 reductase, not only the partner of cytochrome P450].

TL;DR: In this paper, it has been shown in mice that CPR was necessary for the action of cytochrome P450 monooxygenase system, but this system is not crucial for animal surviving.
Book ChapterDOI

Computational Techniques Application in Environmental Exposure Assessment

TL;DR: In this chapter, the application of computational techniques in environmental exposure assessment was described, and a novel modelling methodology that links QSPR and MM has been implemented.
Journal ArticleDOI

In vitro to in vivo extrapolation to support the development of the next generation risk assessment (NGRA) strategy for nanomaterials.

Karolina Jagiello, +1 more
- 21 Apr 2022 - 
TL;DR: This work shows the adverse outcome pathway (AOP)-based methodology for the identification of mechanistically relevant events serving as biomarkers for the targeted selection of in vitro assays and discusses the limitations of models applied thus far to study the fate of chemicals in the human body.
Journal ArticleDOI

Predicting electrophoretic mobility of TiO2, ZnO, and CeO2 nanoparticles in natural waters: The importance of environment descriptors in nanoinformatics models.

TL;DR: In this paper , a quantitative structure-property relationship modeling method used in nanoinformatics (nano-QSPR) was successfully applied to predict environmental fate-relevant properties (electrophoretic mobility) of nano-NPs.
Journal ArticleDOI

Using AOP-Wiki to support the ecotoxicological risk assessment of nanomaterials: first steps in the development of novel Adverse Outcome Pathways

TL;DR: The development of Adverse Outcome Pathways (AOPs) that are relevant for nanomaterials (NMs) is focusing mainly on their human toxicity, but there is an additional component of nanosafety that...